GCM
MRK icon

Gabalex Capital Management’s Merck MRK Stock Holding History

Gabalex Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-120,000
Closed -$10.3M – 10
2022
Q3 		$10.3M Buy
120,000
+20,000
+20% +$1.79M 5.7% 11
2022
Q2 		$9.12M Hold
100,000
– – 5.29% 13
2022
Q1 		$8.21M Hold
100,000
– – 3.78% 13
2021
Q4 		$7.66M Sell
100,000
-60,000
-38% -$4.78M 3.26% 15
2021
Q3 		$12M Hold
160,000
– – 5.56% 10
2021
Q2 		$12.4M Buy
160,000
+2,800
+2% +$208K 5.85% 6
2021
Q1 		$11.6M Buy
157,200
+9,348
+6% +$690K 5.84% 6
2020
Q4 		$11.5M Sell
147,852
-35,548
-19% -$2.72M 6.25% 5
2020
Q3 		$14.5M Buy
183,400
+52,400
+40% +$4.1M 4.06% 11
2020
Q2 		$9.67M Hold
131,000
– – 3.04% 14
2020
Q1 		$9.62M Hold
131,000
– – 3.31% 14
2019
Q4 		$11.4M Hold
131,000
– – 2.98% 16
2019
Q3 		$10.5M Hold
131,000
– – 2.84% 15
2019
Q2 		$10.5M Buy
131,000
+26,200
+25% +$2.01M 2.73% 14
2019
Q1 		$8.32M Hold
104,800
– – 2.4% 14
2018
Q4 		$7.64M Hold
104,800
– – 2.39% 15
2018
Q3 		$7.09M Hold
104,800
– – 1.94% 18
2018
Q2 		$6.07M Hold
104,800
– – 1.79% 18
2018
Q1 		$5.45M Hold
104,800
– – 1.64% 17
2017
Q4 		$5.63M Sell
104,800
-52,400
-33% -$2.9M 1.62% 16
2017
Q3 		$9.61M Hold
157,200
– – 2.97% 14
2017
Q2 		$9.61M Hold
157,200
– – 3.11% 15
2017
Q1 		$9.53M Sell
157,200
-131,000
-45% -$7.95M 2.97% 16
2016
Q4 		$16.2M Hold
288,200
– – 5.47% 10
2016
Q3 		$17.2M Hold
288,200
– – 6.01% 9
2016
Q2 		$15.8M Hold
288,200
– – 5.77% 10
2016
Q1 		$14.6M Hold
288,200
– – 5.04% 12
2015
Q4 		$14.5M Hold
288,200
– – 5.59% 10
2015
Q3 		$13.6M Buy
288,200
+183,400
+175% +$9.74M 5.29% 10
2015
Q2 		$5.69M Buy
+104,800
New +$5.88M 2.05% 14

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gabalex Capital Management's MRK Position: Q4 2022 in Review

Gabalex Capital Management sold out of Merck (MRK) in Q4 2022, closing a stake of 120,000 shares — an estimated $10.3M sold.

Gabalex Capital Management first reported a position in MRK in Q2 2015 and held it in 30 quarters. The position peaked at $17.2M in Q3 2016. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Gabalex Capital Management reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • Gabalex Capital Management sold 120,000 Merck shares in Q4 2022, an estimated $10.3M.
  • Gabalex Capital Management first reported a position in Merck in Q2 2015 and held it in 30 quarters.
  • Gabalex Capital Management's Merck position peaked at $17.2M in Q3 2016.
  • 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Gabalex Capital Management's 13F filing for Q4 2022.